Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus

Syeda Naqvi, Shabnam Naveed, Zeeshan Ali, Syed Masroor Ahmad, Raad Asadullah Khan, Honey Raj, Shoaib Shariff, Chintan Rupareliya, Fatima Zahra, Saba Khan, Syeda Naqvi, Shabnam Naveed, Zeeshan Ali, Syed Masroor Ahmad, Raad Asadullah Khan, Honey Raj, Shoaib Shariff, Chintan Rupareliya, Fatima Zahra, Saba Khan

Abstract

Context: Dyslipidemia is quite prevalent in non-insulin dependent diabetes mellitus. Maintaining tight glycemic along with lipid control plays an essential role in preventing micro- and macro-vascular complications associated with diabetes.

Purpose: The main purpose of the study was to highlight the relationship between glycosylated hemoglobin (HbA1c) and triglyceride levels. This may in turn help in predicting the triglyceride status of type 2 diabetics and therefore identifying patients at increased risk from cardiovascular events. Hypertriglyceridemia is one of the common risk factors for coronary artery disease in type 2 diabetes mellitus (DM). Careful monitoring of the blood glucose level can be used to predict lipid status and can prevent most of the complications associated with the disease.

Method: This is a cross-sectional study using data collected from the outpatient diabetic clinic of Jinnah Postgraduate Medical Centre (JPMC) Karachi, Pakistan. Patients of age 18 years and above were recruited from the clinic. A total of consenting 509 patients of type 2 diabetes mellitus were enrolled over a period of 11 months. For statistical analysis, SPSS Statistics for Windows, Version 17.0 ( IBM Corp, Armonk, New York) was used and Chi-square and Pearson's correlation coefficient was used to find the association between triglyceride and HbA1c. The HbA1c was dichotomized into four groups on the basis of cut-off. Chi-square was used for association between HbA1c with various cut-off values and high triglyceride levels. Odds-ratio and its 95% confidence interval were calculated to estimate the level of risk between high triglyceride levels and HbA1c groups. The p-value < 0.05 was considered statistically significant for all the tests applied for significance.

Result: The association of high triglyceride was evaluated in four different groups of HbA1c, with a cut-off seven, eight, nine and 10 respectively. With HbA1c cut-off value of 7%, 74% patients had high triglycerides and showed a significant association with high triglyceride levels at p < 0.001 and odds ratio was 2.038 (95% confidence interval: 1.397 - 2.972). Logistic regression models were adjusted for demographic factors (age, race, gender), lifestyle factors (smoking, body mass index, lifestyle) and health status factors (blood pressure, physician-rated health status).

Conclusion: After adjusting for relevant covariates, glycated hemoglobin was positively correlated with high triglyceride. Hence, HbA1c can be an indicator of triglyceride level and can be one of the predictors of cardiovascular risk factors in type 2 diabetes mellitus.

Keywords: cardiovascular event; diabetes; diabetes education; dyslipidemia; fasting plasma glucose; hba1c; hypertension; lipid; smoking; triglyceride.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1. Scattered plot showing correlation between…
Figure 1. Scattered plot showing correlation between glycosylated hemoglobin (HbA1c) and triglyceride levels

References

    1. Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management. Sattar N, Gill JM. Lancet Diabetes Endocrinol. 2015;3:1004–1016.
    1. Diabetes in Asians. Rhee EJ. Endocrinol Metab. 2015;30:263–269.
    1. Prevalence of non-communicable diseases and their risk factors at a semi-urban community, Pakistan. Naseem S, Khattak UK, Ghazanfar H, et al. Pan Afr Med J. 2016;23:151.
    1. Management status of cardiovascular disease risk factors for dyslipidemia among Korean adults. Lee J, Son H, Ryu OH. Yonsei Med J. 2017;58:326–338.
    1. Diabetic dyslipidemia review: an update on current concepts and management guidelines of diabetic dyslipidemia. Dake AW, Sora ND. Am J Med Sci. 2016;351:361–365.
    1. Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population. Sarfraz M, Sajid S, Ashraf MA. Saudi J Biol Sci. 2016;23:761–766.
    1. Lipid modification in type 2 diabetes: the role of LDL and HDL. Verges B. Fundam Clin Pharmacol. 2009;23:681–685.
    1. Ama. Moor VJ, Ndongo Amougou S, Ombotto S, et al. Int J Vasc Med. 2017;2017:6061306.
    1. Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease. Mahalle N, Garg MK, Naik SS, et al. Indian J Endocrinol Metab. 2014;18:48–55.
    1. Light chain myeloma-induced severe hypertriglyceridemia. Rahman S, Kumar P, Mahto SK, et al. J Clin Diagn Res. 2017;11:1–3.
    1. Hypertriglyceridemia: the importance of identifying patients at risk. Kushner PA, Cobble ME. Postgrad Med. 2016;128:848–858.
    1. Triglycerides to high-density-lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes. Quispe R, Martin SS, Jones SR. Curr Opin Endocrinol Diabetes Obes. 2016;23:150–156.
    1. Prevalence of hypertriglyceridemic waist and association with risk of type 2 diabetes mellitus: a meta-analysis. Ren Y, Luo X, Wang C, et al. Diabetes Metab Res Rev. 2016;32:405–412.
    1. Prevalence of and risk factors for type 2 diabetes mellitus in hyperlipidemia in China. Chen GY, Li L, Dai F, et al. Med Sci Monit. 2015;21:2476–2484.
    1. Association of comorbid and metabolic factors with optimal control of type 2 diabetes mellitus. Roy S, Sherman A, Monari-Sparks MJ, et al. N Am J Med Sci. 2016;8:31–39.
    1. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Ozder A. Lipids Health Dis. 2014;13:183.
    1. Levels of apolipoprotein a1, b100 and lipoprotein (a) in controlled and uncontrolled diabetic patients and in non-diabetic healthy people. Patel VI, Patel KP, Makadia MG, et al. J Clin Diagn Res. 2017;11:1–5.
    1. Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: comparison of whey, casein, gluten, and cod protein. Mortensen LS, Hartvigsen ML, Brader LJ, et al. Am J Clin Nutr. 2009;90:41–48.
    1. Fasting plasma triglycerides predict the glycaemic response to treatment of type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm. Lebovitz HE, Ludvik B, Yaniv I, et al. Diabetic Med. 2013;30:687–693.
    1. Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia. Parhofer KG. Diabetes Metab J. 2015;39:353–362.
    1. Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia. Hussain A, Ali I, Ijaz M, Rahim A. Ther Adv Endocrinol Metab. 2017;8:51–57.
    1. Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. Valensi P, Avignon A, Sultan A, et al. Cardiovasc Diabetol. 2016;15:104.
    1. Diabetes dyslipidemia. Schofield JD, Liu Y, Rao-Balakrishna P, et al. Diabetes Ther. 2016;7:203–219.
    1. American association of clinical endocrinologists and American College of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease . Jellinger PS, Handelsman Y, Rosenblit PD, et al. Endocr Pract. 2017;23:1–87.
    1. Management of dyslipidemia in patients with hypertension, diabetes, and metabolic syndrome. Srikanth S, Deedwania P. Curr Hypertens Rep. 2016;18:76.
    1. Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. Tenenbaum A, Klempfner R, Fisman EZ. Cardiovasc Diabetol. 2014;13:159.
    1. Fibrates and niacin: Is there a place for them in clinical practice? Wierzbicki AS, Viljoen A. Expert Opin Pharmacother. 2014;15:2673–2680.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren